Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCSW) Liabilities and Shareholders Equity (2021 - 2025)

Historic Liabilities and Shareholders Equity for HeartSciences (HSCSW) over the last 5 years, with Q4 2025 value amounting to $6.0 million.

  • HeartSciences' Liabilities and Shareholders Equity fell 2290.17% to $6.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $22.4 million, marking a year-over-year decrease of 3835.52%. This contributed to the annual value of $4.2 million for FY2025, which is 5556.29% down from last year.
  • According to the latest figures from Q4 2025, HeartSciences' Liabilities and Shareholders Equity is $6.0 million, which was down 2290.17% from $6.4 million recorded in Q3 2025.
  • In the past 5 years, HeartSciences' Liabilities and Shareholders Equity registered a high of $10.8 million during Q1 2024, and its lowest value of $1.9 million during Q2 2021.
  • Over the past 5 years, HeartSciences' median Liabilities and Shareholders Equity value was $5.2 million (recorded in 2022), while the average stood at $5.3 million.
  • Per our database at Business Quant, HeartSciences' Liabilities and Shareholders Equity skyrocketed by 22837.84% in 2024 and then tumbled by 5556.29% in 2025.
  • HeartSciences' Liabilities and Shareholders Equity (Quarter) stood at $1.9 million in 2021, then surged by 147.52% to $4.8 million in 2022, then tumbled by 50.36% to $2.4 million in 2023, then skyrocketed by 228.38% to $7.8 million in 2024, then dropped by 22.9% to $6.0 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $6.0 million for Q4 2025, versus $6.4 million for Q3 2025 and $4.2 million for Q2 2025.